Acceleron Pharma Inc.
LEI 529900TQRID2UY164805 · QID Q16824238
Industry: Biological Products, (No Diagnostic Substances)
Time series: Revenue by fiscal year · Net Income by fiscal year
| Fact | Value | Period | Source |
|---|---|---|---|
| entity_legal_form | {"value": "XTIQ", "elf_code": "XTIQ"} | gleif | |
| headquarters_address | {"city": "WILMINGTON", "region": "US-DE", "street": "c/o CORPORATION SERVICE COMPANY, 251 | gleif | |
| legal_address | {"city": "WILMINGTON", "region": "US-DE", "street": "c/o CORPORATION SERVICE COMPANY, 251 | gleif | |
| legal_jurisdiction | {"value": "US-DE", "scheme": "ISO 3166"} | gleif | |
| legal_name | {"lang": "en-US", "value": "Acceleron Pharma Inc."} | gleif | |
| observed_web_domain | {"via": "wikidata:P856", "domain": "acceleron.com"} | robots_obs | |
| registration_status | {"entity_status": "ACTIVE", "lei_registration_status": "LAPSED"} | gleif | |
| website | {"qid": "Q16824238", "url": "http://www.acceleron.com/", "via": "wikidata"} | wikidata |
Cite as: FACTANKER, https://factanker.com/entity/66be137e-e5dd-4a94-966b-800503e29697